Summary
Overview
Work History
Education
Skills
Publications
Timeline
Generic
Dr. Kiran G Kulirankal

Dr. Kiran G Kulirankal

Registration number: TCMC 45770
Padamugal, Kakkanad, Kochi

Summary

Additional Associate Professor, Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medicals Sciences, Kochi

Overview

13
13
years of professional experience

Work History

Junior resident

MOSC Medical Collage
08.2012 - 03.2013

Senior resident

Amrita Institute of medical sciences
07.2017 - 08.2018

Assistant professor

Amrita Institute of Medical Sciences
09.2017 - 11.2023

Additional Associate Professor

Amrita Institute of Medical Sciences
12.2023 - Current

Education

M.B.B.S -

Malankara Orthodox Syrian Church Medical College
01.2011

M.D - General Medicine

Pondicherry Institute of Medical Sciences
01.2016

Fellowship - General Infectious Diseases (FGID)

CMC Vellore
04.2001 -

Post Graduate Diploma (PGDHIVM) - HIV Medicine

Indira Gandhi National Open University
01.2023

Fellowship - Clinical Infectious Diseases (FCID)

Amrita Institute of Medical Sciences
01.2022

Skills

  • Main practice setting in a >1000 bed hospital and outpatient clinic in a multi-speciality practise over last 9 years along with undergraduate and post graduate teaching
  • Appointed on 12/8/25 as Compliance officer for Amrita Institute of Medical Sciences, under provision of The HIV & AIDS (Prevention & control) Act,2017
  • Experience in treatment of HIV patients, bone and joint infections, endocarditis, post-surgical infections, MRSA, tropical infections, post-transplant infections, outpatient IV antibiotics
  • Involved in antimicrobial stewardship and hospital infection control programs
  • Member of Amrita pharmacovigilance committee
  • Selected as one of the best doctors in Infectious Diseases from South India in the “THE OUTLOOK” magazine for the years 2024 & 2025

Publications

  • Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease Cureus. 2021 Dec; 13(12): e20515. doi: 10.7759/cureus.20515 Published online 2021 Dec 19.
  • Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study Int J Infect Dis. 2022 Sep; 122: 693–702. doi: 10.1016/j.ijid.2022.07.033 Published online 2022 Jul 16.
  • Characterizing COVID-19 transmission risk factors among frontline health-care workers using the WHO risk assessment tool: insights from a tertiary care center in South India IJQHC Communications, Volume 3, Issue 1, 2023, Iyad006, https://doi.org/10.1093/ijcoms/iyad006 Published: 03 June 2023
  • Characterization and predictive risk scoring of long COVID in a south indian cohort after breakthrough COVID infection; a prospective single centre study BMC Infect Dis. 2023; 23: 670. doi: 10.1186/s12879-023-08600-6 Published online 2023 Oct 9.
  • Role of Baricitinib in Moderate-to-severe COVID-19: A Case–Control Study from a South Indian Tertiary Care Setting Journal of Clinical Infectious Diseases Society 1(3):p 233-238, Jul–Sep 2023. | DOI: 10.4103/CIDS.CIDS_49_23 December 05, 2023
  • A Prospective Observational Study on the Association of Serum 25-hydroxy Vitamin D Levels with Clinical Outcomes among COVID-19 Patients Admitted to a Tertiary Care Facility, South India Journal of Clinical Infectious Diseases Society 1(3):p 255-259, Jul–Sep 2023. | DOI: 10.4103/CIDS.CIDS_5_23 Published on December 2023
  • The impact of implementing barrier curtain placement in reducing nosocomial COVID-19 clusters at a tertiary care facility Amrita Journal of Medicine 20(2):p 64-68, April-June 2024. | DOI: 10.4103/AMJM.AMJM_76_23 Date of publishing: June 18, 2024
  • Association of Mean Platelet Volume with Grades of Hypertensive Retinopathy Annals of African Medicine ():10.4103/aam.aam_130_23, April 04, 2024. | DOI: 10.4103/aam.aam_130_23 Date of publishing: July 1, 2024
  • Predicting COVID 19–Associated Pulmonary Aspergillosis Risk in Low- and Middle-Income Countries: A Matched Case-Control Study Open Forum Infectious Diseases, Volume 11, Issue 7, July 2024, Ofae406, https://doi.org/10.1093/ofid/ofae406 Date of publishing: July 23, 2024
  • Exploring COVID-19 vaccine hesitancy in unvaccinated adults within a semi-urban population of South India: A qualitative investigation Clinical Epidemiology and Global Health 29 (2024) 101739 https://doi.org/10.1016/j.cegh.2024.101739 dat31 July, 2024
  • Adopting a model of antimicrobial stewardship program to anti-tubercular treatment stewardship: A single-centre experience from a private tertiary care hospital in South India PLoS One.2024 Nov 5;19(11):e0310493. doi: 10.1371/journal.pone.0310493. eCollection 2024. Date of publishing: November, 2024
  • Early biomarkers in hospitalized patients as predictors of post-acute sequelae of SARS-CoV-2 infection: a one-year cohort study BMC Infect Dis. 2025 Mar 24;25(1):398. doi: 10.1186/s12879-025-10619-w. Date of Publishing: March 2025

Timeline

Additional Associate Professor

Amrita Institute of Medical Sciences
12.2023 - Current

Assistant professor

Amrita Institute of Medical Sciences
09.2017 - 11.2023

Senior resident

Amrita Institute of medical sciences
07.2017 - 08.2018

Junior resident

MOSC Medical Collage
08.2012 - 03.2013

Fellowship - General Infectious Diseases (FGID)

CMC Vellore
04.2001 -

M.D - General Medicine

Pondicherry Institute of Medical Sciences

M.B.B.S -

Malankara Orthodox Syrian Church Medical College

Post Graduate Diploma (PGDHIVM) - HIV Medicine

Indira Gandhi National Open University

Fellowship - Clinical Infectious Diseases (FCID)

Amrita Institute of Medical Sciences
Dr. Kiran G KulirankalRegistration number: TCMC 45770